7National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S]. Approved standard MT-AT(M100- S18). NCCLS, 2006. 被引量：1
8Lim WS,van der Eerden MM, Laing R,et al. Defining community acquired pneumonia severity on presentation to hospital: an International Derivation and Validation Study[J]. Thorax, 2003,59 : 377-382. 被引量：1
9Dudzevicius V, Vttkauskiene A, Sakalauskas R. The influence of the initial antibacterial treatment effectiveness, clinical and etiological factors on nonresolvent severe pneumonia and outcome [J]. Medicina(Kaunas), 2003,39:260-265. 被引量：1
2The University Hospita I Consortium.Adapted from UHC Guidelines for the Use of A1bumin,Nonprotein Colloid,and crystalloid solutions[S].2000-05-01. 被引量：1
